Investor Apeiron Investment Group Ltd.
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Apeiron Investment Group Ltd. . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Add This Fund
to your dashboard

Date Form Target Prev
Shares		 Current
Shares		 Change
(Percent)		 Ownership
(Percent)		 Change
(Percent)
2025-08-18 13D/A IGXT / IntelGenx Technologies Corp. 46,749,092 56,501,513
2025-06-04 13D/A IGXT / IntelGenx Technologies Corp. 44,908,967 46,749,092
2025-02-24 13D IGXT / IntelGenx Technologies Corp. 44,908,967
2025-01-28 13D/A NEUP / Neuphoria Therapeutics Inc. 72,618
2024-10-07 13D/A BNOX / Bionomics Limited - Depositary Receipt (Common Stock) 276,490,501
2024-09-30 13G RZLV / Rezolve AI PLC 18,281,638
2024-02-13 13G/A ATAI / Atai Life Sciences N.V. 32,671,702 33,885,999
2023-06-02 13D/A SNSE / Sensei Biotherapeutics, Inc. 3,441,661 0
2023-05-23 13D/A SNSE / Sensei Biotherapeutics, Inc. 3,441,661 3,441,661
2023-03-09 13D/A SNSE / Sensei Biotherapeutics, Inc. 3,439,461 3,441,661
2023-02-10 13G/A ATAI / Atai Life Sciences N.V. 32,059,504 32,671,702
2022-11-21 13D/A SNSE / Sensei Biotherapeutics, Inc. 3,439,461 3,439,461
2022-11-02 13D/A SNSE / Sensei Biotherapeutics, Inc. 3,439,461 3,439,461
2022-07-19 13D SNSE / Sensei Biotherapeutics, Inc. 3,229,461 3,439,461
2022-02-10 13G/A SNSE / Sensei Biotherapeutics, Inc. 2,651,843 3,229,461
2022-02-10 13G ATAI / Atai Life Sciences N.V. 32,059,504
2021-12-30 13D 402,550,387
2021-02-18 13G SNSE / Sensei Biotherapeutics, Inc. 2,651,843